Metraipolis › archive › dc_2dba2a53e278

Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results — Europe PMC PMID:41420532

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41420532
DOI
10.1210/clinem/dgaf680
License (as archived)
solo-consultazione
Archived
2026-11-02T23:46:15.577Z
SHA-256 of the archived text
1dafaf7fc09299c66edf9c5e3210bbdb25908bf64600e17a5bb024bee1c794ea
Stable URL of this page
https://metraipolis.com/documento/dc_2dba2a53e278

How to cite

Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results — Europe PMC PMID:41420532 — Europe PMC (en), https://europepmc.org/article/MED/41420532 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2dba2a53e278 (Metraipolis archive dc_2dba2a53e278, sha256 1dafaf7fc09299c66edf9c5e3210bbdb25908bf64600e17a5bb024bee1c794ea)
BibTeX
@misc{dc2dba2a53e278,
  title = {Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results — Europe PMC PMID:41420532},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41420532},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2dba2a53e278; sha256 1dafaf7fc09299c66edf9c5e3210bbdb25908bf64600e17a5bb024bee1c794ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41420532. Agents can read the archived copy with the MCP tool read_document.